AI ETI LLC Amends Eliem Therapeutics Stake

Ticker: CLYM · Form: SC 13D/A · Filed: Aug 16, 2024 · CIK: 1768446

Sentiment: neutral

Topics: 13D-filing, amendment, ownership-change

Related Tickers: ELIEM

TL;DR

Access Industries affiliate AI ETI LLC updated its Eliem Therapeutics filing. Watch for more details.

AI Summary

AI ETI LLC, an affiliate of Access Industries, has amended its Schedule 13D filing regarding Eliem Therapeutics, Inc. as of August 16, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or percentage changes are not detailed in this excerpt. The filing is an amendment to a previous submission concerning Eliem Therapeutics, a company in the pharmaceutical preparations sector.

Why It Matters

This amendment signals a potential shift in control or investment strategy by a significant shareholder in Eliem Therapeutics, which could impact the company's stock performance and future direction.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often indicate significant changes in a major shareholder's position, which can lead to increased volatility and uncertainty for the stock.

Key Players & Entities

FAQ

What specific changes in beneficial ownership are detailed in this amendment?

This excerpt does not specify the exact changes in beneficial ownership or the new percentage held by AI ETI LLC. It only states that it is an amendment to a Schedule 13D filing.

What is the CUSIP number for Eliem Therapeutics, Inc. common stock?

The CUSIP number for Eliem Therapeutics, Inc. common stock is 28658R106.

Who are the group members listed in this filing?

The group members listed are Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik.

What is the business address of AI ETI LLC?

The business address of AI ETI LLC is C/O Access Industries, Inc., 40 West 57th Street, 28th Floor, New York, NY 10019.

What is the filing date of this Schedule 13D/A amendment?

The filing date of this Schedule 13D/A amendment is August 16, 2024.

Filing Stats: 1,510 words · 6 min read · ~5 pages · Grade level 15.3 · Accepted 2024-08-16 16:23:26

Key Financial Figures

Filing Documents

From the Filing

SC 13D/A 1 d875635dsc13da.htm SC 13D/A SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Eliem Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 28658R106 (CUSIP Number) Alejandro Moreno Langhorne S. Perrow c/o Access Industries, Inc. 40 West 57 th Street, 28th Floor New York, New York 10019 (212) 247-6400 with copies to: Nicholas P. Pellicani Debevoise & Plimpton LLP 65 Gresham Street EC2V 7NQ London + 44 20 7786 9000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 14, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. CUSIP No. 28658R106 1 NAME OF REPORTING PERSON. AI ETI LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 5,009,400 shares 8 SHARED VOTING POWER 0 shares 9 SOLE DISPOSITIVE POWER 5,009,400 shares 10 SHARED DISPOSITIVE POWER 0 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,009,400 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 7.5% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) Based on an aggregate of 67,060,163 shares of Common Stock issued and outstanding as of August 9, 2024, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission (the SEC) on August 14, 2024. CUSIP No. 28658R106 1 NAME OF REPORTING PERSON. Access Industries Holdings LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 5,009,400 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 5,009,400 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,009,400 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 7.5% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) Based on an aggregate of 67,060,163 shares of Common Stock issued and outstanding as of August 9, 2024, as reported in the Issuers Form 10-Q filed with the SEC on August 14, 2024. CUSIP No. 28658R106 1 NAME OF REPORTING PERSON. Access Industries Management, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 5,009,400 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER 5,009,400 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,009,400 shares 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11); 7.5% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO (Limited Liability Company) (1) Based on an aggregate of 67,060,163 shares of Common Stock issued and outstanding as of August 9, 2024, as reported in the Issuers Form 10-Q filed with the SEC on August 14, 2024. CUSIP No. 28658R106 1 NAME OF REPORTING PERSON. Len Blavatnik 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER 5,009,400 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSIT

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing